Effect of Diabetes on Neurological and Cognitive Outcomes
DOI:
https://doi.org/10.12775/QS.2025.47.66715Keywords
Diabetes mellitus, Ischemic Stroke, Cognitive impairment, DementiaAbstract
Introduction: Diabetes mellitus significantly increases the risk of ischaemic stroke by accelerating atherosclerosis and small vessel disease in the brain, as well as increasing the incidence of atrial fibrillation. Its impact on haemorrhagic stroke, however, remains unclear. Hyperglycaemia worsens the prognosis after a stroke, limits neuroplasticity, and reduces BDNF levels. This leads to poorer functional performance and slower rehabilitation. Diabetes also increases the risk of dementia, including Alzheimer's disease and vascular dementia, via metabolic disorders, endothelial dysfunction and neurodegenerative processes. This paper aims to provide an overview of the mechanisms linking diabetes with stroke, neurological prognosis and dementia risk.
Materials and methods: A review of selected literature in the PubMed, Scopus, Web of Science and Google Schoolar databases was conducted, using the following keywords: “Diabetes mellitus”, “Ischemic Stroke”, “Cognitive impairment”, “Dementia”.
Conclusions: Diabetes significantly increases the risk of ischaemic stroke by accelerating atherosclerosis and small vessel disease, and increasing the risk of atrial fibrillation. Its impact on haemorrhagic stroke, however, remains unclear. Hyperglycaemia worsens the clinical course and post-stroke prognosis by limiting neuroplasticity and regenerative processes. Diabetes also significantly increases the risk of dementia, including Alzheimer's disease and vascular dementia, via a combination of metabolic disorders, vascular changes, and neurodegeneration. These findings highlight the importance of effectively controlling risk factors and intervening early to reduce the neurological burden associated with diabetes.
References
[1] Chen R, Ovbiagele B, Feng W. Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes. Am J Med Sci 2016;351:380–6. https://doi.org/10.1016/j.amjms.2016.01.011
[2] Mosenzon O, Cheng AY, Rabinstein AA, Sacco S. Diabetes and Stroke: What Are the Connections? J Stroke 2023;25:26–38. https://doi.org/10.5853/jos.2022.02306.
[3] Mechtouff L, Rascle L, Crespy V, Canet-Soulas E, Nighoghossian N, Millon A. A narrative review of the pathophysiology of ischemic stroke in carotid plaques: a distinction versus a compromise between hemodynamic and embolic mechanism. Ann Transl Med 2021;9:1208–1208. https://doi.org/10.21037/atm-20-7490.
[4] Poznyak A, Grechko A V., Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. Int J Mol Sci 2020;21:1835. https://doi.org/10.3390/ijms21051835.
[5] Manoria PC, Chopra HK, Parashar SK, Dutta AL, Pinto B, Mullasari A, et al. The nuances of atherogenic dyslipidemia in diabetes: Focus on triglycerides and current management strategies. Indian Heart J 2013;65:683–90. https://doi.org/10.1016/j.ihj.2013.10.015.
[6] Fishman SL, Sonmez H, Basman C, Singh V, Poretsky L. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. Molecular Medicine 2018;24:59. https://doi.org/10.1186/s10020-018-0060-3.
[7] Yuan T, Yang T, Chen H, Fu D, Hu Y, Wang J, et al. New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol 2019;20:247–60. https://doi.org/10.1016/j.redox.2018.09.025.
[8] Keeter WC, Moriarty AK, Galkina E V. Role of neutrophils in type 2 diabetes and associated atherosclerosis. Int J Biochem Cell Biol 2021;141:106098. https://doi.org/10.1016/j.biocel.2021.106098.
[9] Lien C-F, Chen S-J, Tsai M-C, Lin C-S. Potential Role of Protein Kinase C in the Pathophysiology of Diabetes-Associated Atherosclerosis. Front Pharmacol 2021;12. https://doi.org/10.3389/fphar.2021.716332.
[10] Umemura T, Kawamura T, Hotta N. Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalities. J Diabetes Investig 2017;8:134–48. https://doi.org/10.1111/jdi.12545.
[11] Liu J, Rutten-Jacobs L, Liu M, Markus HS, Traylor M. Causal Impact of Type 2 Diabetes Mellitus on Cerebral Small Vessel Disease. Stroke 2018;49:1325–31. https://doi.org/10.1161/STROKEAHA.117.020536.
[12] Yaghi S, Raz E, Yang D, Cutting S, Mac Grory B, Elkind MS, et al. Lacunar stroke: mechanisms and therapeutic implications. J Neurol Neurosurg Psychiatry 2021;92:823–30. https://doi.org/10.1136/jnnp-2021-326308.
[13] Palacio S, McClure LA, Benavente OR, Bazan C, Pergola P, Hart RG. Lacunar Strokes in Patients With Diabetes Mellitus: Risk Factors, Infarct Location, and Prognosis. Stroke 2014;45:2689–94. https://doi.org/10.1161/STROKEAHA.114.005018.
[14] Nepal R, Choudhary M, Dhungana S, Katwal S, Khanal S, Bista M, et al. Prevalence and major cardiac causes of cardio-embolic stroke and in-hospital mortality in Eastern Nepal. J Clin Prev Cardiol 2020;9:19. https://doi.org/10.4103/JCPC.JCPC_57_19.
[15] Aune D, Feng T, Schlesinger S, Janszky I, Norat T, Riboli E. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. J Diabetes Complications 2018;32:501–11. https://doi.org/10.1016/j.jdiacomp.2018.02.004.
[16] Leopoulou M, Theofilis P, Kordalis A, Papageorgiou N, Sagris M, Oikonomou E, et al. Diabetes mellitus and atrial fibrillation-from pathophysiology to treatment. World J Diabetes 2023;14:512–27. https://doi.org/10.4239/wjd.v14.i5.512.
[17] Mavridis A, Viktorisson A, Eliasson B, von Euler M, Sunnerhagen KS. Risk of Ischemic and Hemorrhagic Stroke in Individuals With Type 1 and Type 2 Diabetes. Neurology 2025;104. https://doi.org/10.1212/WNL.0000000000213480.
[18] Sacco S, Foschi M, Ornello R, De Santis F, Pofi R, Romoli M. Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities. Diabetologia 2024;67:1192–205. https://doi.org/10.1007/s00125-024-06146-z.
[19] Hill MD. Stroke and diabetes mellitus, 2014, p. 167–74. https://doi.org/10.1016/B978-0-444-53480-4.00012-6.
[20] Lau L, Lew J, Borschmann K, Thijs V, Ekinci EI. Prevalence of diabetes and its effects on stroke outcomes: A meta‐analysis and literature review. J Diabetes Investig 2019;10:780–92. https://doi.org/10.1111/jdi.12932.
[21] Sacco S, Foschi M, Ornello R, De Santis F, Pofi R, Romoli M. Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities. Diabetologia 2024;67:1192–205. https://doi.org/10.1007/s00125-024-06146-z.
[22] Jin C, Li G, Rexrode KM, Gurol ME, Yuan X, Hui Y, et al. Prospective Study of Fasting Blood Glucose and Intracerebral Hemorrhagic Risk. Stroke 2018;49:27–33. https://doi.org/10.1161/STROKEAHA.117.019189.
[23] Liu J, Rutten-Jacobs L, Liu M, Markus HS, Traylor M. Causal Impact of Type 2 Diabetes Mellitus on Cerebral Small Vessel Disease. Stroke 2018;49:1325–31. https://doi.org/10.1161/STROKEAHA.117.020536.
[24] Yang S, Boudier-Revéret M, Kwon S, Lee MY, Chang MC. Effect of Diabetes on Post-stroke Recovery: A Systematic Narrative Review. Front Neurol 2021;12. https://doi.org/10.3389/fneur.2021.747878.
[25] Lau L, Lew J, Borschmann K, Thijs V, Ekinci EI. Prevalence of diabetes and its effects on stroke outcomes: A meta‐analysis and literature review. J Diabetes Investig 2019;10:780–92. https://doi.org/10.1111/jdi.12932.
[26] Chaturvedi P, Singh A, Tiwari V, Thacker A. Diabetes mellitus type 2 impedes functional recovery, neuroplasticity and quality of life after stroke. J Family Med Prim Care 2020;9:1035. https://doi.org/10.4103/jfmpc.jfmpc_884_19.
[27] Liu W, Wang X, O’Connor M, Wang G, Han F. Brain-Derived Neurotrophic Factor and Its Potential Therapeutic Role in Stroke Comorbidities. Neural Plast 2020;2020:1–13. https://doi.org/10.1155/2020/1969482.
[28] Cao F, Yang F, Li J, Guo W, Zhang C, Gao F, et al. The relationship between diabetes and the dementia risk: a meta-analysis. Diabetol Metab Syndr 2024;16:101. https://doi.org/10.1186/s13098-024-01346-4.
[29] Sato N, Morishita R. Brain Alterations and Clinical Symptoms of Dementia in Diabetes: AÎ2/Tau-Dependent and Independent Mechanisms. Front Endocrinol (Lausanne) 2014;5. https://doi.org/10.3389/fendo.2014.00143.
[30] Čater M, Hölter SM. A Pathophysiological Intersection of Diabetes and Alzheimer’s Disease. Int J Mol Sci 2022;23:11562. https://doi.org/10.3390/ijms231911562.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Angelika Macko, Urszula Justyna Wojciechowska, Bartosz Łuniewski, Iga Maria Nowicka, Jakub Dziemiańczuk, Wiktoria Maria Hrehoruk Macedońska, Justyna Morawska, Monika Olszanska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 235
Number of citations: 0
